Literature DB >> 2946587

The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.

K Nakao, A Sugawara, N Morii, M Sakamoto, T Yamada, H Itoh, S Shiono, Y Saito, K Nishimura, T Ban.   

Abstract

We have analysed the pharmacokinetics of alpha-human atrial natriuretic polypeptide (alpha-hANP) in healthy subjects, using a two-compartment open model following bolus intravenous injection. The plasma half-times for the fast and slow components were 1.7 +/- 0.07 min and 13.3 +/- 1.69 min respectively. V1 (the volume of the central compartment), VZ (volume of distribution) and VSS (volume of distribution at steady-state) were 5370 +/- 855 ml (89.5 +/- 14.3 ml X kg-1), 32000 +/- 4620 ml (533 +/- 77.0 ml X kg-1), and 11900 +/- 1530 ml (198 +/- 25.5 ml X kg-1) respectively. The mean plasma clearance was 1520 +/- 121 ml X min-1 (25.4 +/- 2.0 ml X min-1 X kg-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946587     DOI: 10.1007/bf00870995

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

Review 2.  Atriopeptins as cardiac hormones.

Authors:  P Needleman; S P Adams; B R Cole; M G Currie; D M Geller; M L Michener; C B Saper; D Schwartz; D G Standaert
Journal:  Hypertension       Date:  1985 Jul-Aug       Impact factor: 10.190

3.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

4.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).

Authors:  K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

7.  Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body.

Authors:  A Sugawara; K Nakao; N Morii; M Sakamoto; M Suda; M Shimokura; Y Kiso; M Kihara; Y Yamori; K Nishimura
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

8.  Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide.

Authors:  K Nakao; A Sugawara; N Morii; M Sakamoto; M Suda; J Soneda; T Ban; M Kihara; Y Yamori; M Shimokura
Journal:  Biochem Biophys Res Commun       Date:  1984-11-14       Impact factor: 3.575

9.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

10.  Existence of atrial natriuretic polypeptide in kidney.

Authors:  M Sakamoto; K Nakao; M Kihara; N Morii; A Sugawara; M Suda; M Shimokura; Y Kiso; Y Yamori; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1985-05-16       Impact factor: 3.575

View more
  29 in total

1.  Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.

Authors:  H Meyer-Lehnert; T Bayer; H G Predel; K Glänzer; H J Kramer
Journal:  Klin Wochenschr       Date:  1991-11-26

Review 2.  A heart-adipose tissue connection in the regulation of energy metabolism.

Authors:  Sheila Collins
Journal:  Nat Rev Endocrinol       Date:  2013-12-03       Impact factor: 43.330

Review 3.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

4.  Inhibition of natriuretic peptide receptor 1 reduces itch in mice.

Authors:  Hans Jürgen Solinski; Patricia Dranchak; Erin Oliphant; Xinglong Gu; Thomas W Earnest; John Braisted; James Inglese; Mark A Hoon
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

5.  Ventricular and atrial myocytes of newborn rats synthesise and secrete atrial natriuretic peptide in culture: light- and electron-microscopical localisation and chromatographic examination of stored and secreted molecular forms.

Authors:  C J Hassall; J Wharton; S Gulbenkian; J V Anderson; J Frater; D J Bailey; A Merighi; S R Bloom; J M Polak; G Burnstock
Journal:  Cell Tissue Res       Date:  1988-01       Impact factor: 5.249

6.  ANP is cleared much faster than BNP in patients with congestive heart failure.

Authors:  Kuniko Kimura; Yukinari Yamaguchi; Manabu Horii; Hiroyuki Kawata; Hiromitsu Yamamoto; Shiro Uemura; Yoshihiko Saito
Journal:  Eur J Clin Pharmacol       Date:  2007-05-04       Impact factor: 2.953

7.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  Kinetics of atrial natriuretic peptide in young and elderly subjects.

Authors:  A C Tan; T L Jansen; E F Termond; F G Russel; T Thien; P W Kloppenborg; T J Benraad
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 9.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

10.  Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure.

Authors:  M Yasuhara; M Yamaguchi; H Shimizu; Y Hashimoto; N Hama; H Itoh; K Nakao; R Hori
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.